Sign in

CIK 0001372514

  • Non-accelerated filer
  • Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980443284
Phone
+1 858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy EVP Finance bought 100 shares at $5.25 ($525)
  4. 4 Open-market buy Chief Development Officer bought 1,431 shares at $5.29 ($7,570)
  5. 4 Open-market buy Director bought 5,260 shares at $4.88 ($25,669)
  6. 4 Open-market buy President and CEO bought 3,000 shares at $5.00 ($14,997)
  7. 4 Grant or award EVP Finance acquired 30,000 shares (grant or award)
  8. 4 Grant or award Chief Development Officer acquired 62,500 shares (grant or award)
  9. 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award EVP Finance acquired 2,400 shares (grant or award)
  19. 4 Grant or award President and CEO acquired 15,600 shares (grant or award)
  20. 4 Grant or award Chief Development Officer acquired 15,600 shares (grant or award)

Page 3 of 21 · 406 filings